# Kolis Scientific

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/kolis-scientific

- Industry: Medical Devices & Equipment
- Headquarters: Morrisville, US
- Website: www.tearscience.com
- Total disclosed funding: $15M
- Latest round: Series B (Jan 18, 2007)
- Investors on record: 3

## About

Kolis Scientific Inc. specializes in developing innovative solutions for ocular health, primarily targeting Meibomian gland dysfunction (MGD) and enhancing comfort for contact lens wearers.Founded in 2005 in Morrisville, US, Kolis Scientific Inc. focuses on ocular health technologies. In January 2007, the company raised USD 15 mn in a Series B financing round led by De Novo Ventures and Quaker Partners Management, with participation from Spray Venture Partners. The company has successfully completed one deal to date.Kolis Scientific Inc. develops the TearScience™ system, which is designed to improve ocular surface protection by addressing Meibomian gland dysfunction (MGD). The company offers its products to eye care professionals, optometrists, and ophthalmologists across North America, Europe, and Asia-Pacific, equipping them with effective tools to manage ocular surface diseases.Kolis Scientific Inc. generates revenue through direct-to-consumer sales and partnerships with healthcare providers. Its flagship product, the TearScience™ system, along with ACUVUE® contact lenses, is sold through retail optical stores and eye care professionals, utilizing a mix of one-time purchases and subscription models for regular deliveries.Kolis Scientific Inc. aims to enhance its product lineup with upcoming innovations targeting ocular health. The company is also planning to expand its operations into additional markets within Europe and Asia-Pacific by 2025. The recent funding of USD 15 mn raised in January 2007 will support these initiatives and facilitate further research and development of its product offerings.

## Funding rounds

- Series B, Jan 18, 2007, $15M — Spray Venture Partners, Quaker Partners Management, De Novo Ventures

## Investors

- Spray Venture Partners (https://capitalatlas.ai/funds/spray-venture-partners) — Series B
- Quaker Partners Management (https://capitalatlas.ai/funds/quaker-partners-management) — Series B
- De Novo Ventures (https://capitalatlas.ai/funds/de-novo-ventures) — Series B